Predictors, cost, and outcomes of patients with acute coronary syndrome who receive optimal secondary prevention therapy: Results from the antiplatelet treatment observational registries (APTOR)

International Journal of Cardiology

Volumn 170, Issue 2, 2013, Pages 239-245

  Zeymer, Uwe ^a   Berkenboom, Guy ^b   Coufal, Zdeněk ^c   Belger, Mark ^d   Sartral, Magali ^d   Norrbacka, Kirsi ^d   Bakhai, Ameet ^e,f  

^a KLINIKUM LUDWIGSHAFEN   (Germany)

^b ERASME HOSPITAL   (Belgium)

^c Batova Nemocnice   (Czech Republic)

^d ELI LILLY AND COMPANY   (United States)

^e ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

^f AMORE Health Ltd   (United Kingdom)

Author keywords

Acute coronary syndrome; Costs; Outcomes; Quality of life; Secondary prevention therapy

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; BLEEDING; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DIET THERAPY; DRUG COST; EUROPE; EVIDENCE BASED MEDICINE; FEMALE; HEALTH CARE PLANNING; HUMAN; KINESIOTHERAPY; LOADING DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITY OF LIFE; REGISTER; SECONDARY PREVENTION;

ACUTE CORONARY SYNDROME; COSTS; OUTCOMES; QUALITY OF LIFE; SECONDARY PREVENTION THERAPY;

ACUTE CORONARY SYNDROME; ADRENERGIC BETA-ANTAGONISTS; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ASPIRIN; EUROPE; FEMALE; HEALTH CARE COSTS; HUMANS; MALE; MIDDLE AGED; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION INHIBITORS; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; QUALITY OF LIFE; REGISTRIES; SECONDARY PREVENTION; STENTS; TICLOPIDINE; TREATMENT OUTCOME;

EID: 84889102302     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.10.057     Document Type: Article

References (29)

1. W. Wijns, P. Kolh, and N. Danchin Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Eur Heart J 31 2010 2501 2555
2. J.P. Bassand, C.W. Hamm, and D. Ardissino Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes Eur Heart J 28 2007 1598 1660
3. F. Van de Werf, J. Bax, and A. Betriu Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation: the Task Force on the Management of ST-Segment Elevation Acute Myocardial Infarction of the European Society of Cardiology Eur Heart J 29 2008 2909 2945
4. J.L. Anderson, C.D. Adams, and E.M. Antman ACC/AHA 2007 guidelines for the management of patients with unstable angina/non ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction): developed in collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons: endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine Circulation 116 2007 e148 e304
5. E.M. Antman, M. Hand, and P.W. Armstrong 2007 focused update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to review new evidence and update the ACC/AHA 2004 guidelines for the management of patients with ST-Elevation myocardial infarction, writing on behalf of the 2004 Writing Committee Circulation 117 2008 296 329
6. I. Graham, D. Atar, and K. Borch-Johnsen European guidelines on cardiovascular disease prevention in clinical practice: Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts) Eur J Cardiovasc Prev Rehabil 14 Suppl. 2 2007 S1 S113
7. J. Ferrieres, A. Bakhai, and A. Iniguez Treatment patterns in patients with acute coronary syndrome undergoing percutaneous coronary intervention Curr Med Res Opin 26 2010 2193 2202
8. K.A. Fox, S.G. Goodman, and F.A. Anderson Jr. From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE) Eur Heart J 24 2003 1414 1424
9. R. Brooks EuroQol: the current state of play Health Policy (Amsterdam, Netherlands) 37 1996 53 72
10. Unstable angina and NSTEMI: the early management of unstable angina and non-ST-segment-elevation myocardial infarction NICE guidance CG94 2010
11. British National Formulary. British National Formulary: BNF 59 British National Formulary: BNF 592010.
12. L. Curtis Unit costs of health and social care 2009
13. Department of Health NHS reference costs 2008-2009 2010
14. N. Danchin, F. Dievart, and J.F. Thebaut Predictors of long-term use of evidence-based therapies after non-ST-segment elevation acute coronary syndrome. The S-Temoin survey Int J Cardiol 133 2009 32 40
15. S.V. Erickson, K. Rangarajan, E.M. Kline-Rogers, D.E. Smith, and K.A. Eagle Association between the use of 4 recommended drug categories and patient perceptions of health status following an ACS event J Manag Care Pharm 15 2009 533 542
16. C. Melloni, K.P. Alexander, and F.S. Ou Predictors of early discontinuation of evidence-based medicine after acute coronary syndrome Am J Cardiol 104 2009 175 181
17. D. Mukherjee, J. Fang, S. Chetcuti, M. Moscucci, E. Kline-Rogers, and K.A. Eagle Impact of combination evidence-based medical therapy on mortality in patients with acute coronary syndromes Circulation 109 2004 745 749
18. M.E. van der Elst, M.L. Bouvy, C.J. de Blaey, and A. de Boer Effect of drug combinations on admission for recurrent myocardial infarction Heart 93 2007 1226 1230
19. A.T. Yan, R.T. Yan, and M. Tan Optimal medical therapy at discharge in patients with acute coronary syndromes: temporal changes, characteristics, and 1-year outcome Am Heart J 154 2007 1108 1115
20. I. Al-Zakwani, M. Zubaid, and P. Panduranga Medication use pattern and predictors of optimal therapy at discharge in 8176 patients with acute coronary syndrome from 6 Middle Eastern countries: Data From the Gulf Registry of Acute Coronary Events Angiology 62 2011 447 454
21. A. Mead, G. Atkinson, and D. Albin Dietetic guidelines on food and nutrition in the secondary prevention of cardiovascular disease - evidence from systematic reviews of randomized controlled trials (second update, January 2006) J Hum Nutr Diet 19 2006 401 419
22. R.S. Taylor, A. Brown, and S. Ebrahim Exercise-based rehabilitation for patients with coronary heart disease: systematic review and meta-analysis of randomized controlled trials Am J Med 116 2004 682 692
23. A. Bakhai, J. Ferrieres, and A. Iniguez International data on supportive therapies at 1 year in acute coronary syndrome patients undergoing PCI: results from the APTOR study Eur J Cardiovasc Prev Rehabil 18 2011 518 525
24. T.G. Briffa, S.D. Eckermann, and A.D. Griffiths Cost-effectiveness of rehabilitation after an acute coronary event: a randomised controlled trial Med J Aust 183 2005 450 455
25. P. Dendale, D. Hansen, J. Berger, and M. Lamotte Long-term cost-benefit ratio of cardiac rehabilitation after percutaneous coronary intervention Acta Cardiol 63 2008 451 456
26. R. Taylor, and B. Kirby The evidence base for the cost effectiveness of cardiac rehabilitation Heart 78 1997 5 6
27. C.M. Yu, C.P. Lau, and J. Chau A short course of cardiac rehabilitation program is highly cost effective in improving long-term quality of life in patients with recent myocardial infarction or percutaneous coronary intervention Arch Phys Med Rehabil 85 2004 1915 1922
28. T. Jernberg, P. Johanson, C. Held, B. Svennblad, J. Lindback, and L. Wallentin Association between adoption of evidence-based treatment and survival for patients with ST-elevation myocardial infarction JAMA 305 2011 1677 1684
29. Bramlage P, Messer C, Bitterlich N, et al. The effect of optimal medical therapy on 1-year mortality after acute myocardial infarction. Heart (British Cardiac Society).96:604-9.